BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12970791)

  • 1. Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH-CCS-PCR.
    Qiu J; Gunaratne P; Peterson LE; Khurana D; Walsham N; Loulseged H; Karni RJ; Roussel E; Gibbs RA; Margolin JF; Gingras MC
    Leukemia; 2003 Sep; 17(9):1891-900. PubMed ID: 12970791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of gene expression profiles that segregate patients with childhood leukemia.
    Moos PJ; Raetz EA; Carlson MA; Szabo A; Smith FE; Willman C; Wei Q; Hunger SP; Carroll WL
    Clin Cancer Res; 2002 Oct; 8(10):3118-30. PubMed ID: 12374679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognosis markers in pediatric high-risk acute lymphoblastic leukemia.
    Al-Lamki Z; Wali YA; Wasifuddin SM; Zachariah M; Al-Mjeni R; Li C; Muralitharan S; Al-Kharusi K; Gunaratne P; Peterson L; Gibbs R; Gingras MC; Margolin JF
    Pediatr Hematol Oncol; 2005; 22(7):629-43. PubMed ID: 16166056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of myeloid-specific genes in childhood acute lymphoblastic leukemia - a cDNA array study.
    Niini T; Vettenranta K; Hollmén J; Larramendy ML; Aalto Y; Wikman H; Nagy B; Seppänen JK; Ferrer Salvador A; Mannila H; Saarinen-Pihkala UM; Knuutila S
    Leukemia; 2002 Nov; 16(11):2213-21. PubMed ID: 12399964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
    Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
    Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
    Raetz EA; Perkins SL; Bhojwani D; Smock K; Philip M; Carroll WL; Min DJ
    Pediatr Blood Cancer; 2006 Aug; 47(2):130-40. PubMed ID: 16358311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia.
    De Pittà C; Tombolan L; Campo Dell'Orto M; Accordi B; te Kronnie G; Romualdi C; Vitulo N; Basso G; Lanfranchi G
    Haematologica; 2005 Jul; 90(7):890-8. PubMed ID: 15996926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative expressed sequence hybridization studies of high-hyperdiploid childhood acute lymphoblastic leukemia.
    Gruszka-Westwood AM; Horsley SW; Martinez-Ramirez A; Harrison CJ; Kempski H; Moorman AV; Ross FM; Griffiths M; Greaves MF; Kearney L
    Genes Chromosomes Cancer; 2004 Nov; 41(3):191-202. PubMed ID: 15334542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes.
    Martinez-Delgado B; Meléndez B; Cuadros M; Alvarez J; Castrillo JM; Ruiz De La Parte A; Mollejo M; Bellas C; Diaz R; Lombardía L; Al-Shahrour F; Domínguez O; Cascon A; Robledo M; Rivas C; Benitez J
    Clin Cancer Res; 2004 Aug; 10(15):4971-82. PubMed ID: 15297397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.
    Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D
    Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a new human pre-B acute lymphoblastic leukemia cell line (KMO-90) with 1;19 translocation carrying p53 gene alterations.
    Sotomatsu M; Hayashi Y; Kawamura M; Yugami S; Shitara T
    Leukemia; 1993 Oct; 7(10):1615-20. PubMed ID: 8412323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia.
    Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Fischer U; Dugas M; Hu J; Borkhardt A
    Genes Chromosomes Cancer; 2013 Jun; 52(6):564-79. PubMed ID: 23508829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11).
    Griesinger F; Elfers H; Ludwig WD; Falk M; Rieder H; Harbott J; Lampert F; Heinze B; Hoelzer D; Thiel E
    Leukemia; 1994 Apr; 8(4):542-8. PubMed ID: 7908708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
    Casagrande G; te Kronnie G; Basso G
    Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
    Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.